title: Profound hypertriglyceridemia and weight gain in the first week following initiation of olanzapine: a case report with implications for lipid monitoring guidelines.
authors.affiliation: Department of Psychiatry, University of Washington, Seattle, WA 98115-6073, USA. rjkimmel@uw.edu
authors.forename: Ryan J
authors.initials: RJ
authors.lastname: Kimmel
authors.forename: Mitchell R
authors.initials: MR
authors.lastname: Levy
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects*; D000068180:Aripiprazole; D001569:Benzodiazepines / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy*; D002998:Clonazepam / Q000627:therapeutic use; D003134:Commitment of Persons with Psychiatric Disorders; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced*; D000077213:Lamotrigine; D008055:Lipids / Q000097:blood*; D008297:Male; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D015363:Quinolones / Q000627:therapeutic use; D014227:Triazines / Q000008:administration & dosage; D015430:Weight Gain / Q000187:drug effects
chemical_list: D000927:Anticonvulsants; D014150:Antipsychotic Agents; D008055:Lipids; D010879:Piperazines; D015363:Quinolones; D014227:Triazines; D001569:Benzodiazepines; D002998:Clonazepam; D000068180:Aripiprazole; D000077152:Olanzapine; D000077213:Lamotrigine